Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

September 1, 1997; Volume 38,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Agis, Hermine

    1. You have access
      Inhalation Scintigraphy with Iodine-123-Labeled Interferon Gamma-lb: Pulmonary Deposition and Dose Escalation Study in Healthy Volunteers
      Irene Virgolini, Amir Kurtaran, Maria Leimer, Peter Smith-Jones, Hermine Agis, Peter Angelberger, Kurt Kletter, Peter Valent, Werner Linkesch and Hans-Georg Eichler
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1475-1481;
  2. Aldrich, Rita

    1. You have access
      Avoiding Solid Waste Contamination Problems from Iodine-131 Patients
      Carol S. Marcus and Rita Aldrich
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 26N;
  3. Amanullah, Aman M.

    1. You have access
      Clinical Validation of Automatic Quantitative Defect Size in Rest Technetium-99m-Sestamibi Myocardial Perfusion SPECT
      Xingping Kang, Daniel S. Berman, Kenneth F. Van Train, Aman M. Amanullah, Joseph Areeda, John D. Friedman, Hosen Kiat and Guido Germano
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1441-1446;
  4. Ambrose, K. R.

    1. You have access
      Effects of Configuration on the Myocardial Uptake of Radioiodinated 3(R)-BMIPP and 3(S)-BMIPP in Rats
      Q. Lin, H. Luo, F. Mokler, A. L. Beets, K. R. Ambrose, D. W. McPherson, J. Kropp and F. F. Knapp
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1434-1441;
  5. Angelberger, Peter

    1. You have access
      Inhalation Scintigraphy with Iodine-123-Labeled Interferon Gamma-lb: Pulmonary Deposition and Dose Escalation Study in Healthy Volunteers
      Irene Virgolini, Amir Kurtaran, Maria Leimer, Peter Smith-Jones, Hermine Agis, Peter Angelberger, Kurt Kletter, Peter Valent, Werner Linkesch and Hans-Georg Eichler
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1475-1481;
  6. Areeda, Joseph

    1. You have access
      Clinical Validation of Automatic Quantitative Defect Size in Rest Technetium-99m-Sestamibi Myocardial Perfusion SPECT
      Xingping Kang, Daniel S. Berman, Kenneth F. Van Train, Aman M. Amanullah, Joseph Areeda, John D. Friedman, Hosen Kiat and Guido Germano
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1441-1446;
  7. Atsumi, Hiroyuki

    1. You have access
      Iodine-123-BMIPP Imaging in Unstable Angina: A Guide for Interventional Strategy
      Yasuchika Takeishi, Satomi Fujiwara, Hiroyuki Atsumi, Kazuei Takahashi, Hiroyasu Sukekawa and Hitonobu Tomoike
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1407-1411;
  8. Baldwin, Ronald M.

    1. You have access
      Test/Retest Reproducibility of Iodine-123-βCIT SPECT Brain Measurement of Dopamine Transporters in Parkinson's Patients
      John P. Seibyl, Kenneth Marek, Kimberly Sheff, Ronald M. Baldwin, Sami Zoghbi, Yolanda Zea-Ponce, Dennis S. Charney, Christopher H. van Dyck, Paul B. Hoffer and Robert B. Innis
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1453-1459;
  9. Bax, Jeroen J.

    1. You have access
      Heterogeneity of DMIPP Uptake and Its Relationship with Heterogeneous Myocardial Blood Flow
      Gerrit W. Sloof, Frans C. Visser, Emile F. I. Comans, Albert B. J. Groeneveld, Jeroen J. Bax, Machiel J. van Eenige, Ger J. van der Vusse and Furn F. Knapp
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1424-1430;
  10. Beck, Daniel

    1. You have access
      Evaluating Bone Marrow Metastasis of Neuroblastoma with Iodine-123-MIBG Scintigraphy and MRI
      Nour-Eddine Lebtahi, François Gudinchet, Maja Nenadov-Beck, Daniel Beck and Angelika Bischof Delaloye
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1389-1392;
« Previous (Pages : 1 2 3 4 5 6 ... 25) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 38, Issue 9
September 1, 1997
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire